Inhibition of p63 transcriptional activity by p14ARF: functional and physical link between human ARF tumor suppressor and a member of the p53 family

Molecular and Cellular Biology
Viola CalabròGirolama La Mantia

Abstract

The ARF/MDM2/p53 pathway is a principal defense mechanism to protect the organism from uncontrolled effects of deregulated oncogenes. Oncogenes activate ARF, which interacts with and inhibits the ubiquitin ligase MDM2, resulting in p53 stabilization and activation. Once stabilized and activated, p53 can either induce or repress a wide array of different gene targets, which in turn can regulate cell cycle, DNA repair, and a number of apoptosis-related genes. Here we show that, unlike p53, p63, a member of the p53 family, directly interacts with p14(ARF). Through this interaction ARF inhibits p63-mediated transactivation and transrepression. In p63-transfected cells, ARF, which normally localizes into nucleoli, accumulates in the nucleoplasm. Based on these observations, we suggest that stimuli inducing p14(ARF) expression can, at the same time, activate p53 and impair p63 transcriptional activity, altering the pattern of p53 target gene expression. Here we show, for the first time, a physical and functional link between the p14(ARF) tumor suppressor protein and p63, a member of the p53 family.

References

Jan 1, 1993·Science·S N AgoffB Wu
May 15, 1997·Nature·Y HauptM Oren
May 15, 1997·Nature·M H KubbutatK H Vousden
Sep 26, 1997·Nature·K PolyakB Vogelstein
Oct 9, 1998·Genes & Development·C J Sherr
Aug 6, 1999·Oncogene·E BálintK H Vousden
Aug 19, 1999·Protein Science : a Publication of the Protein Society·C D Thanos, J U Bowie
Nov 13, 1999·Nature Cell Biology·J D WeberD Bar-Sagi
Dec 14, 1999·The Journal of Biological Chemistry·M Oren
Mar 14, 2000·Molecular and Cellular Biology·J D WeberC J Sherr
Apr 25, 2000·Experimental Cell Research·M S LindströmC E Asker
May 10, 2000·Current Biology : CB·T Caspari
May 10, 2000·Current Biology : CB·M A LohrumK H Vousden
Sep 20, 2000·Genes & Development·J D WeberG P Zambetti
Jun 5, 2001·Nature Cell Biology·M C MoroniK Helin
Nov 21, 2001·The Journal of Biological Chemistry·Viola CalabròGirolama La Mantia
Jan 31, 2002·Trends in Genetics : TIG·Annie YangFrank McKeon
Feb 28, 2002·Apoptosis : an International Journal on Programmed Cell Death·E S Hickman, K Helin
Mar 7, 2002·Trends in Molecular Medicine·Hans van Bokhoven, Frank McKeon
Mar 9, 2002·Biochemical and Biophysical Research Communications·Tiziana ParisiGirolama La Mantia
May 31, 2002·American Journal of Human Genetics·Hans van Bokhoven, Han G Brunner
Nov 26, 2002·The Journal of Biological Chemistry·Helen RizosRichard F Kefford
Nov 26, 2002·Molecular and Cellular Biology·Abhishek DattaPradip Raychaudhuri
Nov 26, 2002·Molecular and Cellular Biology·Zach SerberVolker Dötsch
Nov 26, 2002·Molecular and Cellular Biology·Pamela GhioniLuisa Guerrini
Mar 7, 2003·Molecular Cell·Masataka SugimotoCharles J Sherr
Aug 29, 2003·Oncogene·Angelika WaltermannMatthias Dobbelstein
Dec 11, 2003·The Journal of Biological Chemistry·Alessandra PolliceGirolama La Mantia
Jan 20, 2004·Genes & Development·Maranke I KosterDennis R Roop
Jan 28, 2004·Cell·Charles J Sherr

❮ Previous
Next ❯

Citations

Aug 18, 2006·Nature Reviews. Cancer·Charles J Sherr
Oct 27, 2010·Nature Reviews. Clinical Oncology·Chit Fang CheokDavid P Lane
Feb 1, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·O B Poli NetoJ M de Andrade
Mar 10, 2012·PloS One·Yelena MirochnikOlga V Volpert
Sep 23, 2008·FEBS Letters·Alessandra PolliceGirolama La Mantia
Dec 30, 2015·International Journal of Molecular Sciences·Sabita N SaldanhaTrygve O Tollefsbol
Jan 26, 2010·Actas dermo-sifiliográficas·S BloethnerR Kumar
Sep 26, 2006·Journal of Cellular Physiology·Bétrice Petre-LazarHervé Coffigny
Mar 7, 2019·Biomolecules·Rosa FontanaMaria Vivo
Feb 8, 2006·Oncogene·R KommaganiM P Kadakia
Sep 28, 2005·Birth Defects Research. Part C, Embryo Today : Reviews·Maria I Morasso, Nadezda Radoja
Apr 12, 2006·Oncogene·L GonzálezI Palmero
Jan 14, 2012·Expert Opinion on Therapeutic Targets·Alexander H Stegh
Oct 20, 2006·Molecular Cancer Research : MCR·Tina M CasertaMadhavi P Kadakia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis